By analyzing FABP4 expression in TAMs with human breast cancer specimens, we found that FABP4 expression in TAMs, especially CD163+ TAMs, correlated directly with tumor size, grade, metastasis and even patient survival. Here, CD163 is linked to breast carcinoma.